Effects of Pioglitazone on Suppressor of Cytokine Signaling 3 Expression
Potential Mechanisms for Its Effects on Insulin Sensitivity and Adiponectin Expression
Article Information
vol. 56 no. 3 795-803
PubMed
Published By
Print ISSN
Online ISSN
History
- November 26, 2006
- July 26, 2006
- Published in print February 27, 2007.
Copyright & Usage
DIABETES
Author Information
- Yukiko Kanatani1,
- Isao Usui1,
- Ken Ishizuka1,
- Agussalim Bukhari1,
- Shiho Fujisaka1,
- Masaharu Urakaze1,
- Tetsuro Haruta1,
- Tadamitsu Kishimoto2,
- Tetsuji Naka3 and
- Masashi Kobayashi1
- 1The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan
- 2Osaka University Graduate School of Frontier Bioscience, Osaka, Japan
- 3Laboratory for Immune Signal, National Institute of Biomedical Innovation, Osaka, Japan
- Address correspondence and reprint requests to Isao Usui, MD, PhD, The First Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama 930-0194, Japan. E-mail: isaousui-tym{at}umin.ac.jp
Statistics from Altmetric.com
Article usage
In this Issue
March 2007, 56(3)
Effects of Pioglitazone on Suppressor of Cytokine Signaling 3 Expression
